WO2023086978 - BRANCHED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS
National phase entry:
Publication Number
WO/2023/086978
Publication Date
19.05.2023
International Application No.
PCT/US2022/079788
International Filing Date
14.11.2022
Title **
[English]
BRANCHED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS
[French]
COMPOSÉS D'ACIDE NUCLÉIQUE MODIFIÉ À TRIPLE LIPIDE RAMIFIÉ
Applicants **
NOVARTIS AG
Inventors
ALLERSON, Charles
SUCKOW, Arthur, T.
Priority Data
63/279,269
15.11.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 7801 | |
| EPO | Filing, Examination, Granting | 169410 | |
| Japan | Filing, Examination, Granting | 5312 | |
| South Korea | Filing, Examination, Granting | 11784 | |
| USA | Filing, Examination, Granting | 34910 |
Total:
229,217
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed herein are compounds including a nucleic acid (A), their preparation, and their use.[French]
L'invention concerne des composés comprenant un acide nucléique (A), leur préparation et leur utilisation.